Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Enveric Biosciences, Inc. Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results November 13, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Reports Second Quarter 2023 Corporate and Financial Results August 14, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Two Poster Presentations at the Canadian Chemistry Conference and Exhibition (CSC 2023) June 07, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Receives Notice of Allowance from USPTO for EVM301 Series of Drug Candidates June 05, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Poster Presentation at Canadian Neuroscience Meeting 2023 May 30, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Receives Notice of Allowance From USPTO for C4-Carboxylic Acid-Substituted Tryptamine Derivatives for Next Generation Psilocin Prodrug May 24, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Manuscript Detailing the Development of Novel Psilocin Prodrugs for the Treatment of Anxiety and Other Mental Health Disorders May 22, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences to Participate in 2023 BIO International Convention in Boston May 19, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Receives Notice of Allowance from USPTO for Novel Prodrug of Psilocin May 18, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Reports First Quarter 2023 Financial Results and Operational Highlights May 15, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month May 02, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results April 03, 2023 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 August 31, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Appoints New Independent Directors July 27, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Closing of $8 Million Registered Direct and Private Placement Offerings, Priced at a Premium to Market Under Nasdaq Rules July 26, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces $8 Million Registered Direct Offering and Private Placement, Priced at a Premium to Market Under Nasdaq Rules July 25, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Formation of Scientific Advisory Board to Drive Further Growth of Next-Generation Mental Health Medicines July 19, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Announces Reverse Stock Split July 14, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio July 13, 2022 From Enveric Biosciences, Inc. Via Business Wire Tickers ENVB Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.